S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NYSE:CHE

Chemed Stock Forecast, Price & News

$433.25
+12.72 (+3.02 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$417.41
Now: $433.25
$436.56
50-Day Range
$420.53
MA: $502.83
$556.02
52-Week Range
$330.01
Now: $433.25
$560.00
Volume130,212 shs
Average Volume104,695 shs
Market Capitalization$6.95 billion
P/E Ratio26.27
Dividend Yield0.32%
Beta0.55
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Chemed logo

Headlines

A Look Into Chemed's Price Over Earnings - Yahoo Finance
February 24, 2021 |  finance.yahoo.com
Recap: Chemed Q4 Earnings - Yahoo Finance
February 24, 2021 |  finance.yahoo.com
Chemed Q4 Profit Rises - Nasdaq
February 23, 2021 |  nasdaq.com
Recap: Chemed Q4 Earnings - Benzinga
February 23, 2021 |  benzinga.com
Recap: Chemed Q4 Earnings
February 23, 2021 |  finance.yahoo.com
Chemed Reports Fourth-Quarter 2020 Results - Business Wire
February 23, 2021 |  businesswire.com
Chemed Reports Fourth-Quarter 2020 Results
February 23, 2021 |  finance.yahoo.com
Relative Strength Alert For Chemed - Nasdaq
February 22, 2021 |  nasdaq.com
Earnings Preview: Chemed - Yahoo Finance
February 22, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
CUSIP16359R10
Phone513-762-6690
Employees16,641
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.94 billion
Cash Flow$14.11 per share
Book Value$45.39 per share

Profitability

Net Income$219.92 million

Miscellaneous

Market Cap$6.95 billion
Next Earnings Date4/27/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

2.54 out of 5 stars

Medical Sector

13th out of 1,972 stocks

Home Health Care Services Industry

1st out of 9 stocks

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
$433.25
+12.72 (+3.02 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Chemed (NYSE:CHE) Frequently Asked Questions

Is Chemed a buy right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Chemed stock.
View analyst ratings for Chemed
or view top-rated stocks.

What stocks does MarketBeat like better than Chemed?

Wall Street analysts have given Chemed a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Chemed wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Chemed?

Chemed saw a drop in short interest in the month of January. As of January 29th, there was short interest totaling 157,200 shares, a drop of 19.7% from the January 14th total of 195,700 shares. Based on an average daily trading volume, of 90,600 shares, the days-to-cover ratio is currently 1.7 days. Currently, 1.0% of the shares of the stock are sold short.
View Chemed's Short Interest
.

When is Chemed's next earnings date?

Chemed is scheduled to release its next quarterly earnings announcement on Tuesday, April 27th 2021.
View our earnings forecast for Chemed
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) issued its quarterly earnings data on Monday, February, 22nd. The company reported $5.13 earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of $5.13. The firm earned $533 million during the quarter, compared to the consensus estimate of $537.20 million. Chemed had a trailing twelve-month return on equity of 38.13% and a net margin of 13.11%. The business's revenue was up 2.0% compared to the same quarter last year. During the same period last year, the company earned $4.22 earnings per share.
View Chemed's earnings history
.

How has Chemed's stock been impacted by Coronavirus (COVID-19)?

Chemed's stock was trading at $414.05 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CHE stock has increased by 4.6% and is now trading at $433.25.
View which stocks have been most impacted by COVID-19
.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Friday, February 19th. Stockholders of record on Monday, March 1st will be paid a dividend of $0.34 per share on Friday, March 19th. This represents a $1.36 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date of this dividend is Friday, February 26th.
View Chemed's dividend history
.

Is Chemed a good dividend stock?

Chemed pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.32%. Chemed has been increasing its dividend for 12 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Chemed is 9.75%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Chemed will have a dividend payout ratio of 7.51% next year. This indicates that Chemed will be able to sustain or increase its dividend.
View Chemed's dividend history.

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY21 earnings guidance on Tuesday, February, 23rd. The company provided EPS guidance of $17.00-17.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $17.28.

What price target have analysts set for CHE?

2 brokers have issued 1-year target prices for Chemed's stock. Their forecasts range from $535.00 to $580.00. On average, they expect Chemed's share price to reach $557.50 in the next twelve months. This suggests a possible upside of 28.7% from the stock's current price.
View analysts' price targets for Chemed
or view top-rated stocks among Wall Street analysts.

Who are Chemed's key executives?

Chemed's management team includes the following people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 67, Pay $4.86M)
  • Mr. David P. Williams, Exec. VP & CFO (Age 60, Pay $2.31M)
  • Mr. Spencer S. Lee, Exec. VP (Age 65, Pay $1.44M)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 42, Pay $1.79M)
  • Mr. Michael D. Witzeman CPA, MBA, VP & Controller (Age 50)
  • Ms. Lisa A. Reinhard, VP, Chief Admin. Officer & Assistant Sec.
  • Sherri Warner, Director of Investor Relations
  • Mr. Brian C. Judkins, VP, Sec. & Chief Legal Officer (Age 41)
  • Mr. Thomas C. Hutton, VP & Director (Age 70)

What is Kevin J. McNamara's approval rating as Chemed's CEO?

1 employees have rated Chemed CEO Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among Chemed's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Chemed's key competitors?

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), The Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), The Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (9.18%), Wells Fargo & Company MN (3.26%), Riverbridge Partners LLC (2.32%), Renaissance Technologies LLC (1.64%), JPMorgan Chase & Co. (1.58%) and Janus Henderson Group PLC (1.21%). Company insiders that own Chemed stock include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Patrick P Grace, Spencer S Lee and Walter L Krebs.
View institutional ownership trends for Chemed
.

Which major investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Renaissance Technologies LLC, Aristotle Capital Boston LLC, Squarepoint Ops LLC, First Trust Advisors LP, Citigroup Inc., Skandinaviska Enskilda Banken AB publ , and Keeley Teton Advisors LLC. Company insiders that have sold Chemed company stock in the last year include Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Patrick P Grace, and Spencer S Lee.
View insider buying and selling activity for Chemed
or view top insider-selling stocks.

Which major investors are buying Chemed stock?

CHE stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, Wells Fargo & Company MN, JPMorgan Chase & Co., Morgan Stanley, UBS Asset Management Americas Inc., Eaton Vance Management, Eaton Vance Management, and Riverbridge Partners LLC.
View insider buying and selling activity for Chemed
or or view top insider-buying stocks.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $433.25.

How much money does Chemed make?

Chemed has a market capitalization of $6.95 billion and generates $1.94 billion in revenue each year. The company earns $219.92 million in net income (profit) each year or $13.95 on an earnings per share basis.

How many employees does Chemed have?

Chemed employs 16,641 workers across the globe.

What is Chemed's official website?

The official website for Chemed is www.chemed.com.

Where are Chemed's headquarters?

Chemed is headquartered at 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.